SGT-003 in the INSPIRE DUCHENNE trial to date - - Robust microdystrophin expression with consistent mechanistic evidence of dystrophin associated protein complex (DAPC) restoration and improvements in ...
Detailed price information for Solid Biosciences Inc (SLDB-Q) from The Globe and Mail including charting and trades.
Dyne Therapeutics (NasdaqGS:DYN) has initiated the Phase 3 Harmonia trial of DYNE-101 in myotonic dystrophy type 1, following alignment with the FDA on the study design. The Harmonia trial is a ...
SGT-003 in the INSPIRE DUCHENNE trial to date - - Robust microdystrophin expression with consistent mechanistic evidence of dystrophin associated protein complex ...
Briefly on MSN
Cape Town Cycle Tour: Cyclist Who Suffered Fatal Medical Emergency Identified as Mike Wilson
The Cape Town Cycle Tour tragedy claims Mike Wilson, an experienced cyclist who suffered a cardiac arrest during the race, ...
'Historic day': Province announces $59 million over three years for cardiac care in southern Alberta
The province has committed $59 million over three years to expand cardiac services and intensive-care capacity in southern Alberta. “Expanding their treatment and diagnostic capacity will enable ...
Late-breaking presentation of results from the Phase 3 CORALreef AddOn trial evaluating enlicitide decanoate, Merck’s investigational oral PCSK9 inhibitor, which may help address the cardiovascular ...
Merck to present new data from cardio-pulmonary pipeline at the ACC.26 in New Orleans, from March 28-30: Rahway, New Jersey Tuesday, March 17, 2026, 17:00 Hrs [IST] Merck, known a ...
The arterial vasculature is the second most frequently calcified structure in the human body after the skeleton. Calcification of the aorta and aortic valves occurs in most individuals in westernized ...
Citi is making a clear statement about the health of U.S. medical technology heading into the spring: the sector’s fundamentals remain intact, even as broader market volatility has dragged down some ...
Solid Biosciences Inc. shares dropped more than 8% on Wednesday after the company released data from its Duchenne gene therapy trial. Trading in the stock was briefly halted earlier in the day. The ...
At one point, what I think was the worst point, my memory was so bad that somebody asked me what my name was, like, at a front desk, and I could not remember my own name. Every woman's perimenopause ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results